Format

Send to

Choose Destination
Int J Environ Res Public Health. 2018 May 23;15(6). pii: E1055. doi: 10.3390/ijerph15061055.

Governance on the Drug Supply Chain via Gcoin Blockchain.

Author information

1
Division of Risk Management, Taiwan Food and Drug Administration, No.161-2, Kunyang St, Nangang District, Taipei City 11561, Taiwan. 1692tjh@fda.gov.tw.
2
Department of Computer Science and Information Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei 10617, Taiwan. b03902103@ntu.edu.tw.
3
College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, China. chongbin@pku.edu.cn.
4
Department of Computer Science and Information Engineering, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei 10617, Taiwan. liao@csie.ntu.edu.tw.

Abstract

As a trust machine, blockchain was recently introduced to the public to provide an immutable, consensus based and transparent system in the Fintech field. However, there are ongoing efforts to apply blockchain to other fields where trust and value are essential. In this paper, we suggest Gcoin blockchain as the base of the data flow of drugs to create transparent drug transaction data. Additionally, the regulation model of the drug supply chain could be altered from the inspection and examination only model to the surveillance net model, and every unit that is involved in the drug supply chain would be able to participate simultaneously to prevent counterfeit drugs and to protect public health, including patients.

KEYWORDS:

Gcoin; blockchain; drug supply chains

PMID:
29882861
PMCID:
PMC6025275
DOI:
10.3390/ijerph15061055
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center